Skip to content

Opko Health OPK Q3 2024 earnings

Reported November 7, 2024 · After market close

Revenue$173.6MBeat by $18.2M
EPS$0.03Beat by $0.13
Revenue estimate$155.4M
EPS estimate-$0.10

Next report

Date not yet announced

Financials

Q3 2024

Income statement

See full
Revenue$173.6M-2.8%
Gross profit$40.1M-49.5%
Operating income-$67.2M
Net income$24.9M+129%
EPS (diluted)$0.03

Balance sheet

See full
Total debt$72.9M+25.0%
Total equity$1.4B-2.8%
Total assets$2.3B+9.7%

Cash flow

See full
Operating cash flow-$77.1M-333%
CapEx$7.9M+88.8%
Free cash flow-$85.0M

Valuation & ratios

Valuation

as of 09/30/24
See full
Market cap$1.04B-13.6%
Enterprise value$1.11B-0.9%
P/S1.5×+0.1×

Profitability

See full
Gross margin30%-5.8pp
Net margin-18.8%-3.3pp
FCF margin-28.1%

Returns & leverage

See full
Return on equity-9.4%-2.2pp
Debt / equity0.1×0.0×
Current ratio+1.2×

Segments

By geography

See full
US$132.7M
CL$16.6M
IE$11.5M
ES$6.3M
MX$5.6M

By product

See full
Rayaldee$15.9M
Transfer Of Intellectual Property And Other$13.2M
Intellectual Property And Other$13.2M

Versus estimates

Ask the moment Opko Health reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Opko Health report Q3 2024 earnings?
Opko Health (OPK) reported Q3 2024 earnings on November 7, 2024 after market close.
What were Opko Health's Q3 2024 revenue and EPS?
Opko Health reported revenue of $173.6M and eps of $0.03 for Q3 2024.
Did Opko Health beat estimates in Q3 2024?
Revenue beat the consensus estimate of $155.4M by $18.2M. EPS beat the consensus estimate of $-0.10 by $0.13.
Where can I find Opko Health's Q3 2024 SEC filings?
You can read the 10-Q periodic report (0001437749-24-033931) directly on SEC EDGAR. The filing index links above go to sec.gov.